Keyphrases
Prostate Cancer
83%
Multiparametric MRI (mpMRI)
51%
Metabolic Pathway
29%
Neuroendocrine Cancer
29%
Sex Differences
28%
Tumor
27%
Prostate
25%
Visceral Fat
24%
NCCN Guidelines
24%
Metabolism
22%
Glycolysis
22%
Clinically Significant Prostate Cancer
21%
Poor Prognosis
19%
Magnetic Resonance Imaging
19%
Positron Emission Tomography
18%
Body Composition
17%
Overall Survival
16%
Glioma
14%
Neuroendocrine Cells
14%
Cancer Metabolism
13%
Computed Tomography
13%
PH-sensitive
13%
Extracellular pH
13%
Subcutaneous Adipose Tissue
12%
Visceral Adipose Tissue
12%
Recurrent Disease
12%
Bitter Melon Extract
11%
Oral Cancer
11%
Lipogenesis
11%
Theranostic Platform
11%
Spatial Proteomics
11%
Renal Cell Carcinoma
11%
Sex-specific
11%
Calcium Carbonate Nanoparticles
11%
Cocaine
11%
Acetylcholine Receptor (AChR)
11%
Nicotinic Acetylcholine Receptor (nAChR)
11%
Cancer Genome Atlas
11%
Image Interpretation
11%
Solid Tumors
10%
Obesity
10%
Tumor Metabolism
10%
Patients with Prostate Cancer
10%
Localized Disease
10%
Radiologists
10%
Tumor Metastasis
9%
Metabolomics
9%
Risk Stratification
9%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
9%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
9%
Medicine and Dentistry
Prostate Cancer
100%
Malignant Neoplasm
69%
Magnetic Resonance Imaging
56%
Neoplasm
32%
Disease
25%
Visceral Fat
24%
Positron Emission Tomography
22%
Metabolism
22%
Computer Assisted Tomography
21%
Sex Difference
20%
Metabolomics
18%
Cancer Cell
17%
Adipose Tissue
17%
Ganglioglioma
17%
Gamma-Aminobutyric Acid
17%
Recurrent Disease
15%
Overall Survival
15%
Biopsy
15%
Metastatic Carcinoma
15%
Transgenic Mouse
14%
Multiparametric Magnetic Resonance Imaging
14%
Positron Emission Tomography
13%
Clear Cell Renal Cell Carcinoma
12%
Endometrial Cancer
11%
Oral Cancer
11%
Lipogenesis
11%
Proteomics
11%
Signal Transduction
9%
Magnetic Resonance Imaging of Prostate
9%
Risk Stratification
9%
Prostate Specific Antigen
9%
Localized Disease
9%
Radioactive Tracer
8%
Obesity
8%
Tumor Metabolism
8%
In Vitro
8%
Biological Marker
8%
Subcutaneous Fat
7%
Glucose Metabolism
7%
Solid Malignant Neoplasm
7%
Body Mass Index
7%
Metabolite
7%
Carbon 11
7%
Cell Metabolism
7%
Glioblastoma
7%
Cancer Prevention
7%
Neuroendocrine Differentiation
7%
Positron Emission Tomography-Computed Tomography
6%
Prostate Cancer Diagnosis
6%
Adenosine Triphosphate
6%